Literature DB >> 26012508

Psychiatric considerations in the oncology setting.

Reema D Mehta1, Andrew J Roth2.   

Abstract

An aging population and advances in diagnostics and treatment have resulted in a rapidly growing population of people impacted by cancer. People live longer after a cancer diagnosis and tolerate more aggressive treatments than in the past. Younger patients struggle with diversions from the normal developmental milestones in career and relationships, while older patients deal with the dual challenges of aging and cancer. Cancer's transition from likely death to survival has increased interest in its impact on psychosocial issues and quality of life, rather than just longevity. In this article, the authors review the psychiatric diagnosis and management of the mental health issues most often encountered in oncology. Oncology treatment teams, including oncologists, nurses, social workers, and other ancillary staff, are often on the front lines of addressing psychiatric distress and clinical syndromes when psychiatrists are not easily available. The purpose of this review article is to highlight opportunities for nonpsychiatrists to improve identification and treatment of psychosocial distress and psychiatric syndromes and to request formal psychiatric consultation in appropriate situations. Psychotherapeutic, psychopharmacologic, cognitive, and behavioral-oriented interventions, as well as supportive interventions, are discussed for treating patients who are facing challenges during active cancer treatment, survivorship, and at the end of life. This review is not exhaustive but highlights the more common psychosomatic medicine and palliative care scenarios that impact cancer patient care. The importance of recognizing and addressing burnout and compassion fatigue in multidisciplinary professionals who care for those treated for cancer is also discussed given the secondary impact this can have on patient care.
© 2015 American Cancer Society.

Entities:  

Keywords:  antidepressants; anxiety; anxiolytics; burnout; delirium; depression; neuroleptics; psycho-oncology; psychotherapy; quality of life

Mesh:

Substances:

Year:  2015        PMID: 26012508     DOI: 10.3322/caac.21285

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  21 in total

1.  Antidepressants appear safe in patients with carcinoid tumor: Results of a retrospective review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Afton Bergel; Stacy Eagle; Fernando Espi Forcen; Reema Mehta; Konstantina Matsoukas; Jonathan Wills; Diane Reidy-Lagunes; Yesne Alici
Journal:  Eur J Surg Oncol       Date:  2018-03-21       Impact factor: 4.424

Review 2.  Opioid Prescribing in an Opioid Crisis: What Basic Skills Should an Oncologist Have Regarding Opioid Therapy?

Authors:  Joseph Arthur; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2019-04-01

3.  Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.

Authors:  Yan Cheng; Xing-Hua Gao; Xian-Jing Li; Qiu-Hua Cao; Dan-Dan Zhao; Jin-Rong Zhou; Hong-Xi Wu; Yun Wang; Lin-Jun You; Hong-Bao Yang; Yun-Long He; Yong-Ren Li; Jin-Song Bian; Qing-Yi Zhu; Lutz Birnbaumer; Yong Yang
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

4.  Must antidepressants be avoided in patients with neuroendocrine tumors? Results of a systematic review.

Authors:  Elie Isenberg-Grzeda; Meredith MacGregor; Konstantina Matsoukas; Ngai Chow; Diane Reidy-Lagunes; Yesne Alici
Journal:  Palliat Support Care       Date:  2020-10

5.  Disparities in healthcare utilization and access by length of cancer survivorship among population-based female cancer survivors.

Authors:  Kate E Dibble; Maneet Kaur; Avonne E Connor
Journal:  J Cancer Surviv       Date:  2021-10-18       Impact factor: 4.062

6.  Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma.

Authors:  Shehzad Niazi; Ryan D Frank; Mayank Sharma; Vivek Roy; Steve Ames; Teresa Rummans; Aaron Spaulding; Taimur Sher; Meghna Ailawadhi; Kirtipal Bhatia; Salman Ahmed; Winston Tan; Asher Chanan-Khan; Sikander Ailawadhi
Journal:  Blood Adv       Date:  2018-05-22

7.  Prospective analysis of psychological differences between adult and elderly cancer patients during postoperative adjuvant chemotherapy.

Authors:  M M Muñoz-Sánchez; C Calderon; P Jimenez-Fonseca; M C Soriano-Rodríguez; C Jara; T García-García; C Beato; J Rogado; B Castelo; R Hernández; M Mangas-Izquierdo; A Carmona-Bayonas
Journal:  Clin Transl Oncol       Date:  2018-06-04       Impact factor: 3.405

8.  Cohort study of oncologic emergencies in patients with head and neck cancer.

Authors:  Cielito C Reyes-Gibby; Stephanie C Melkonian; Ehab Y Hanna; Sai-Ching J Yeung; Charles Lu; Mark S Chambers; Srinivas R Banala; Gary B Gunn; Sanjay S Shete
Journal:  Head Neck       Date:  2017-03-27       Impact factor: 3.821

9.  Factors contributing to cancer-related suicide: A study of root-cause analysis reports.

Authors:  Maya Aboumrad; Brian Shiner; Natalie Riblet; Peter D Mills; Bradley V Watts
Journal:  Psychooncology       Date:  2018-07-18       Impact factor: 3.894

10.  Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.

Authors:  Pareesa Kamgar-Dayhoff; Tinatin I Brelidze
Journal:  Oncotarget       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.